Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Removal Of ‘Legal’ And ‘Implicit’ Terms Cleared Way For ICH Q12 Guideline

Jan 11 2020

• By Joanne S. Eglovitch

Businessman sinking in heap of documents and asking for help — ICH Q12 Should Ease Postapproval Reporting Burden • Source: Shutterstock

Related Content

EMA Fee Revisions Expected To Resolve EC's Objections To ICH Q12 Guideline

Oct 02 2019

US FDA Trains Reviewers For Consistency On Post-Q12 Manufacturing Changes

Jul 18 2019

Lack Of Harmonization In ICH Q12 Draft Guideline Draws Fire In US

Apr 11 2019

Differences Put Aside As ICH Finalizes Guide On Post Approval Changes

Dec 02 2019

Performance-Based Conditions Could Ease Post-Approval Changes For Process Analytical Technologies, Experts Say

Mar 12 2019

EU Pharma Slams ICH Proposal For Selective Adoption Of Quality Guideline

Jan 09 2019

Why Industry Says Global Post-Approval Complexity Must Change

Aug 09 2016

Related Companies

Novartis AG

GSK plc

Intarcia Therapeutics, Inc.

Sanofi

Additional Topics

Manufacturing Quality BioPharmaceutical

More from Manufacturing

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window